SERUM LIPOPROTEIN CHANGES DURING ATENOLOL TREATMENT OF ESSENTIAL-HYPERTENSION

被引：60

作者：

ELIASSON, K

LINS, LE

ROSSNER, S

机构：

[1] KING GUSTAF V RES INST,BOX 60004,S-10401 STOCKHOLM 60,SWEDEN

[2] KAROLINSKA INST,DEPT INTERNAL MED,S-10401 STOCKHOLM 60,SWEDEN

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1981年 / 20卷 / 05期

关键词：

D O I：

10.1007/BF00615401

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：335 / 338

页数：4

共 19 条

[1] SERUM LIPIDS, HYPERTENSION AND CORONARY ARTERY DISEASE [J].

ALBRINK, MJ ;

MAN, EB ;

MEIGS, JW .

AMERICAN JOURNAL OF MEDICINE, 1961, 31 (01) :4-+

[2]

AMES RP, 1976, LANCET, V1, P721

[3]

BERGLUND G, 1978, OBSERVANDA MEDICA FE, V5, P39

[4]

CARLSON K, 1973, J CLIN PATHOL S5, V26, P32

[5]

CARLSON LA, 1972, LANCET, V1, P865

[6] QUANTITATIVE AND QUALITATIVE SERUM LIPOPROTEIN ANALYSIS .1. STUDIES IN HEALTHY MEN AND WOMEN [J].

CARLSON, LA ;

ERICSSON, M .

ATHEROSCLEROSIS, 1975, 21 (03) :417-433

[7] METABOLIC CONSEQUENCES OF ATENOLOL AND PROPRANOLOL IN TREATMENT OF ESSENTIAL HYPERTENSION [J].

DAY, JL ;

SIMPSON, N ;

METCALFE, J ;

PAGE, RL .

BRITISH MEDICAL JOURNAL, 1979, 1 (6156) :77-80

[8] THE EFFECT OF METOPROLOL AND ATENOLOL ON PLASMA HIGH-DENSITY LIPOPROTEIN LEVELS IN MAN [J].

ENGLAND, JDF ;

SIMONS, LA ;

GIBSON, JC ;

CARLTON, M .

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1980, 7 (03) :329-333

[9]

FLETCHER MJ, 1978, J CLIN CHIM ACTA, V22, P393

[10]

LEREN P, 1980, LANCET, V2, P4

← 1 2 →